[
{
"numtree":"1.0.0.0",
"id":"1",
"nametree":"Authors and legal information",
"tocnametree":"Authors and legal information",
"htmlpage":"ENAS5281_1.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.0.0.0",
"id":"2",
"nametree":"Dx and personalised medicine",
"tocnametree":"Dx and personalised medicine",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.1.0.0",
"id":"3",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_2.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.2.0.0",
"id":"4",
"nametree":"A personalised medicine synopsis",
"tocnametree":"A personalised medicine synopsis",
"htmlpage":"ENAS5281_2.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.0.0.0",
"id":"5",
"nametree":"Staging and risk assessment",
"tocnametree":"Staging and risk assessment",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.1.0.0",
"id":"6",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_3.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.2.0.0",
"id":"7",
"nametree":"TNM staging",
"tocnametree":"TNM staging",
"htmlpage":"ENAS5281_3.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.3.0.0",
"id":"8",
"nametree":"Anatomic stage/ prognostic groups",
"tocnametree":"Anatomic stage/ prognostic groups",
"htmlpage":"ENAS5281_3.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.0.0.0",
"id":"9",
"nametree":"Mgmt. of advanced/ metastatic disease",
"tocnametree":"Mgmt. of advanced/ metastatic disease",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.1.0.0",
"id":"10",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_4.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.2.0.0",
"id":"11",
"nametree":"Mgmt. algo. for stage IV SCC and NSCC",
"tocnametree":"Mgmt. algo. for stage IV SCC and NSCC",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.2.1.0",
"id":"12",
"nametree":"Treatment for stage IV SCC",
"tocnametree":"Treatment for stage IV SCC",
"htmlpage":"ENAS5281_4.2.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.2.2.0",
"id":"13",
"nametree":"Treatment for stage IV NSCC",
"tocnametree":"Treatment for stage IV NSCC",
"htmlpage":"ENAS5281_4.2.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.3.0.0",
"id":"14",
"nametree":"First-line treatment",
"tocnametree":"First-line treatment",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.3.1.0",
"id":"15",
"nametree":"EGFR- and ALK-negative disease",
"tocnametree":"EGFR- and ALK-negative disease",
"htmlpage":"ENAS5281_4.3.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.3.2.0",
"id":"16",
"nametree":"SCC",
"tocnametree":"SCC",
"htmlpage":"ENAS5281_4.3.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.3.3.0",
"id":"17",
"nametree":"NSCC",
"tocnametree":"NSCC",
"htmlpage":"ENAS5281_4.3.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.4.0.0",
"id":"18",
"nametree":"PS 2 and beyond",
"tocnametree":"PS 2 and beyond",
"htmlpage":"ENAS5281_4.4.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.5.0.0",
"id":"19",
"nametree":"Elderly patients",
"tocnametree":"Elderly patients",
"htmlpage":"ENAS5281_4.5.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.6.0.0",
"id":"20",
"nametree":"Maintenance",
"tocnametree":"Maintenance",
"htmlpage":"ENAS5281_4.6.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.7.0.0",
"id":"21",
"nametree":"Second-line Tx",
"tocnametree":"Second-line Tx",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.7.1.0",
"id":"22",
"nametree":"EGFR- and ALK-negative disease",
"tocnametree":"EGFR- and ALK-negative disease",
"htmlpage":"ENAS5281_4.7.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.7.2.0",
"id":"23",
"nametree":"SCC",
"tocnametree":"SCC",
"htmlpage":"ENAS5281_4.7.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.7.3.0",
"id":"24",
"nametree":"NSCC",
"tocnametree":"NSCC",
"htmlpage":"ENAS5281_4.7.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.8.0.0",
"id":"25",
"nametree":"EGFR-mutated NSCLC pts",
"tocnametree":"EGFR-mutated NSCLC pts",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.8.1.0",
"id":"26",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_4.8.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.8.2.0",
"id":"27",
"nametree":"Tx for IIIB–IV w/ EGFR mutation",
"tocnametree":"Tx for IIIB–IV w/ EGFR mutation",
"htmlpage":"ENAS5281_4.8.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.9.0.0",
"id":"28",
"nametree":"ALK-rearranged NSCLC patients",
"tocnametree":"ALK-rearranged NSCLC patients",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.9.1.0",
"id":"29",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_4.9.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.9.2.0",
"id":"30",
"nametree":"Tx for IIIB-IV w/ ALK translocation",
"tocnametree":"Tx for IIIB-IV w/ ALK translocation",
"htmlpage":"ENAS5281_4.9.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.10.0.0",
"id":"31",
"nametree":"Role of RT in stage IV NSCLC",
"tocnametree":"Role of RT in stage IV NSCLC",
"htmlpage":"ENAS5281_4.10.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.11.0.0",
"id":"32",
"nametree":"Palliative surgery in stage IV NSCLC",
"tocnametree":"Palliative surgery in stage IV NSCLC",
"htmlpage":"ENAS5281_4.11.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.12.0.0",
"id":"33",
"nametree":"Minim.-invasive proce. in IV NSCLC",
"tocnametree":"Minim.-invasive proce. in IV NSCLC",
"htmlpage":"ENAS5281_4.12.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.13.0.0",
"id":"34",
"nametree":"Role of palliative care in stage IV NSCLC",
"tocnametree":"Role of palliative care in stage IV NSCLC",
"htmlpage":"ENAS5281_4.13.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.14.0.0",
"id":"35",
"nametree":"Focus on brain and bone metastases",
"tocnametree":"Focus on brain and bone metastases",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.14.1.0",
"id":"36",
"nametree":"Brain metastases",
"tocnametree":"Brain metastases",
"htmlpage":"ENAS5281_4.14.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.14.2.0",
"id":"37",
"nametree":"Bone metastases",
"tocnametree":"Bone metastases",
"htmlpage":"ENAS5281_4.14.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.15.0.0",
"id":"38",
"nametree":"Tx of oligometastatic NSCLC",
"tocnametree":"Tx of oligometastatic NSCLC",
"htmlpage":"ENAS5281_4.15.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"5.0.0.0",
"id":"39",
"nametree":"Response evaluation",
"tocnametree":"Response evaluation",
"htmlpage":"ENAS5281_5.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.0.0.0",
"id":"40",
"nametree":"Follow-up",
"tocnametree":"Follow-up",
"htmlpage":"ENAS5281_6.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.0.0.0",
"id":"41",
"nametree":"Summary of recommendations",
"tocnametree":"Summary of recommendations",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"7.1.0.0",
"id":"42",
"nametree":"Dx and personalised medicine",
"tocnametree":"Dx and personalised medicine",
"htmlpage":"ENAS5281_7.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.2.0.0",
"id":"43",
"nametree":"Staging and risk assessment",
"tocnametree":"Staging and risk assessment",
"htmlpage":"ENAS5281_7.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.0.0",
"id":"44",
"nametree":"Mgmt. of advanced/ metastatic disease",
"tocnametree":"Mgmt. of advanced/ metastatic disease",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"7.3.1.0",
"id":"45",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5281_7.3.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.2.0",
"id":"46",
"nametree":"First-line treatment",
"tocnametree":"First-line treatment",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"7.3.2.1",
"id":"47",
"nametree":"EGFR- and ALK-negative disease",
"tocnametree":"EGFR- and ALK-negative disease",
"htmlpage":"ENAS5281_7.3.2.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.2.2",
"id":"48",
"nametree":"SCC",
"tocnametree":"SCC",
"htmlpage":"ENAS5281_7.3.2.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.2.3",
"id":"49",
"nametree":"NSCC",
"tocnametree":"NSCC",
"htmlpage":"ENAS5281_7.3.2.3",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.3.0",
"id":"50",
"nametree":"PS 2 and beyond",
"tocnametree":"PS 2 and beyond",
"htmlpage":"ENAS5281_7.3.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.4.0",
"id":"51",
"nametree":"Elderly patients",
"tocnametree":"Elderly patients",
"htmlpage":"ENAS5281_7.3.4.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.5.0",
"id":"52",
"nametree":"Maintenance",
"tocnametree":"Maintenance",
"htmlpage":"ENAS5281_7.3.5.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.6.0",
"id":"53",
"nametree":"Second-line treatment",
"tocnametree":"Second-line treatment",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"7.3.6.1",
"id":"54",
"nametree":"EGFR- and ALK-negative disease",
"tocnametree":"EGFR- and ALK-negative disease",
"htmlpage":"ENAS5281_7.3.6.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.6.2",
"id":"55",
"nametree":"SCC",
"tocnametree":"SCC",
"htmlpage":"ENAS5281_7.3.6.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.6.3",
"id":"56",
"nametree":"NSCC",
"tocnametree":"NSCC",
"htmlpage":"ENAS5281_7.3.6.3",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.7.0",
"id":"57",
"nametree":"EGFR-mutated NSCLC patients",
"tocnametree":"EGFR-mutated NSCLC patients",
"htmlpage":"ENAS5281_7.3.7.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.8.0",
"id":"58",
"nametree":"ALK-rearranged NSCLC patients",
"tocnametree":"ALK-rearranged NSCLC patients",
"htmlpage":"ENAS5281_7.3.8.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.9.0",
"id":"59",
"nametree":"Role of RT in stage IV NSCLC",
"tocnametree":"Role of RT in stage IV NSCLC",
"htmlpage":"ENAS5281_7.3.9.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.10.0",
"id":"60",
"nametree":"Palliative surgery in stage IV NSCLC",
"tocnametree":"Palliative surgery in stage IV NSCLC",
"htmlpage":"ENAS5281_7.3.10.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.11.0",
"id":"61",
"nametree":"Minim.-invasive proce. in IV NSCLC",
"tocnametree":"Minim.-invasive proce. in IV NSCLC",
"htmlpage":"ENAS5281_7.3.11.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.12.0",
"id":"62",
"nametree":"Role of palliative care in stage IV NSCLC",
"tocnametree":"Role of palliative care in stage IV NSCLC",
"htmlpage":"ENAS5281_7.3.12.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.13.0",
"id":"63",
"nametree":"Focus on brain and bone metastases",
"tocnametree":"Focus on brain and bone metastases",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"7.3.13.1",
"id":"64",
"nametree":"Brain metastases",
"tocnametree":"Brain metastases",
"htmlpage":"ENAS5281_7.3.13.1",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.13.2",
"id":"65",
"nametree":"Bone metastases",
"tocnametree":"Bone metastases",
"htmlpage":"ENAS5281_7.3.13.2",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.3.14.0",
"id":"66",
"nametree":"Treatment of oligometastatic NSCLC",
"tocnametree":"Treatment of oligometastatic NSCLC",
"htmlpage":"ENAS5281_7.3.14.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.4.0.0",
"id":"67",
"nametree":"Response evaluation",
"tocnametree":"Response evaluation",
"htmlpage":"ENAS5281_7.4.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.5.0.0",
"id":"68",
"nametree":"Follow-up",
"tocnametree":"Follow-up",
"htmlpage":"ENAS5281_7.5.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"8.0.0.0",
"id":"69",
"nametree":"Glossary",
"tocnametree":"Glossary",
"htmlpage":"ENAS5281_8.0.0.0",
"haspdf":false,
"emailContent":true
}
]